Alvotech (NASDAQ:ALVOW – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 15th, there was short interest totaling 1,309 shares, a growth of 60.6% from the September 30th total of 815 shares. Based on an average trading volume of 1,621 shares, the days-to-cover ratio is presently 0.8 days.
Alvotech Price Performance
Shares of NASDAQ ALVOW opened at $0.15 on Wednesday. Alvotech has a 52-week low of $0.12 and a 52-week high of $1.14. The business has a fifty day moving average of $0.35 and a two-hundred day moving average of $0.29.
About Alvotech
Alvotech is a biotechnology company focused on developing and manufacturing biosimilar medicines. Biosimilars are biologic products designed to be highly similar to approved reference medicines and may provide additional treatment options in areas with significant healthcare costs. The company’s portfolio targets therapeutic categories including immunology, ophthalmology, oncology and other chronic conditions.
Alvotech operates an integrated business model that covers biosimilar research, cell-line development, process development, clinical testing and commercial-scale manufacturing.
See Also
- Five stocks we like better than Alvotech
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
